$SCYX SCYNEXIS INC Insider Trading
Get free email notifications about insider trading in SCYNEXIS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
Overview of insider trading in SCYNEXIS INC. Insider overview, share value development, latest insider transactions and email notifications about new events in SCYNEXIS INC for free.
CIK Number: 0001178253
IRS Number: 562181648
Industry: PHARMACEUTICAL PREPARATIONS 
Trading Symbol: SCYX
Company Address: 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY 07302-6548
Phone number: 919-544-8600
Former name: Scyrex, Inc.
SCYNEXIS, Inc. is a biotechnology company, which engages in the development of novel oral and intravenous triterpenoid antifungal for the treatment of several serious fungal infections, including vulvovaginal candidiasis, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections. The company was founded by Scot Kevin Huber, Terry Eugene Marquardt, Pierre Bernard Jacques Monnet, Russell J. Outcalt, and Yves Joseph Ribeill on November 4, 1999 and is headquartered in Jersey City, NJ.
Market Capitalization: $82.53M
Prev close: $3.15
Average Daily Volume: 374,508
Days Low: $3.07
Year Low: $1.74
Year High: $5.51
SCYNEXIS INC Insiders Active In Last 3 Months
|Name||Position||Total Shares||Current Value ($)||Last 3 Months||Buy / Sell||Last Transaction|
|Coyne Christine||Chief Commercial Officer||15,000||47,250||shares bought: 15,000 / shares sold: 0||BUY||May 12 2021||2 days ago|
SCYNEXIS INC Latest Insider Transactions
|Date||Ticker||Company||Owner||Relationship||Transaction||Code||Cost ($)||Shares||Transaction Value ($)||Total Shares||% Holdings|
|May 12 2021||SCYX||SCYNEXIS INC||Coyne Christine||Chief Commercial Of ...||Option Exercise||A||6.50||125,000||812,500||125,000|
|May 12 2021||SCYX||SCYNEXIS INC||Coyne Christine||Chief Commercial Of ...||Grant||A||0.00||15,000||0||15,000||0 to 15 K|
|Feb 02 2021||SCYX||SCYNEXIS INC||Taglietti Marco||Chief Executive Off ...||Option Exercise||A||7.47||170,000||1,269,900||170,000|
|Feb 02 2021||SCYX||SCYNEXIS INC||Sukenick Scott||General Counsel||Option Exercise||A||7.47||40,000||298,800||40,000|
|Feb 02 2021||SCYX||SCYNEXIS INC||Francois Eric||Chief Financial Off ...||Option Exercise||A||7.47||65,000||485,550||65,000|
|Feb 02 2021||SCYX||SCYNEXIS INC||Angulo Gonzalez David||Chief Medical Offic ...||Option Exercise||A||7.47||65,000||485,550||65,000|
|Jan 26 2021||SCYX||SCYNEXIS INC||PERCEPTIVE ADVISORS LLC||10% Owner||Sell||S||8.95||33,849||302,949||1,800,000||1.8 M to 1.8 M (-1.85 %)|
|Jan 26 2021||SCYX||SCYNEXIS INC||PERCEPTIVE ADVISORS LLC||10% Owner||Sell||S||8.16||285,151||2,326,832||1,833,849||2.1 M to 1.8 M (-13.46 %)|
|Jan 26 2021||SCYX||SCYNEXIS INC||PERCEPTIVE ADVISORS LLC||10% Owner||Sell||S||7.38||95,000||701,100||2,120,000||2.2 M to 2.1 M (-4.29 %)|
|Jan 26 2021||SCYX||SCYNEXIS INC||PERCEPTIVE ADVISORS LLC||10% Owner||Sell||S||7.43||185,000||1,374,550||2,215,000||2.4 M to 2.2 M (-7.71 %)|
|Dec 23 2020||SCYX||SCYNEXIS INC||Tinmouth Brian Philippe||Director||Option Exercise||A||8.25||4,000||33,000||4,000|
|Dec 23 2020||SCYX||SCYNEXIS INC||Tinmouth Brian Philippe||Director||Option Exercise||A||7.33||4,000||29,320||4,000|
|Dec 23 2020||SCYX||SCYNEXIS INC||Tinmouth Brian Philippe||Director||Buy||P||6.25||8,000||50,000||8,000||0 to 8 K|
|Dec 23 2020||SCYX||SCYNEXIS INC||Taglietti Marco||Chief Executive Off ...||Option Exercise||A||8.25||20,000||165,000||20,000|
|Dec 23 2020||SCYX||SCYNEXIS INC||Taglietti Marco||Chief Executive Off ...||Option Exercise||A||7.33||20,000||146,600||20,000|